Blockage of blood vessels due to atherosclerosis is one of the main causes of mortality and morbidity in the United States resulting in 600,000 blood vessel replacement or revascularization procedures each year at a cost of over 1 billion dollars. Unfortunately, autologous grafts are often not an option for as many as one third of patients and synthetic grafts used to replace small-diameter blood vessels have high rates of failure due to thrombosis and neointimal hyperplasia. This proposal will investigate a bioengineering approach to improve the function and safety of synthetic grafts, specifically expanded polytetrafluoroethylene (ePTFE). The overall goal of this proposal is to evaluate whether an endothelial progenitor cells (EPC)-derived bioengineered ePTFE graft is feasible for patients with confirmed peripheral arterial disease (PAD) and to investigate the safety and efficacy of bioengineered grafts in a large animal model. In particular, we will investigate the use of pioglitazone, a peroxisome proliferator-activated receptor ? (PPAR-?) agonist, as a novel strategy to increase EPC colony formation and cell proliferation as patients with PAD have been reported to have reduced EPC numbers with impaired function. During the pre-clinical trials of this proposal we will develop cell isolation and cell-seeding protocols that can be readily adapted for use in the hospital setting.
The specific aims are to: 1. assess whether circulating EPCs from patients with PAD are a viable cell source for a cell-based bioengineered vascular graft, and 2. evaluate the safety and efficacy of the bioengineered ePTFE grafts in an atherosclerotic swine carotid artery ePTFE bypass model. Given the widespread nature of atherosclerosis and peripheral artery disease, the innovative approach taken in this proposal is expected to directly improve patient care of millions of Americans. This proposal will allow us to gather the necessary expertise and data to design a clinical trial to assess early stage efficacy of the bioengineered grafts.
Blockage of blood vessels due to atherosclerosis is one of the main causes of mortality and morbidity in the United States resulting in 600,000 blood vessel replacement or revascularization procedures each year at a cost of over 1 billion dollars. This proposal will combine advances in progenitor cell research and biomaterial design to improve the function and safety of synthetic grafts, specifically expanded polytetrafluoroethylene (ePTFE). During the pre-clinical trials of this proposal we will develop cell isolation and cell-seeding protocols that can be readily adapted for use in the hospital setting.
|Jiang, Bin; Wu, Yidi; Haney, Chad R et al. (2017) Assessment of an engineered endothelium via single-photon emission computed tomography. Biotechnol Bioeng 114:2371-2378|
|Jiang, Bin; Suen, Rachel; Wang, Jiao-Jing et al. (2017) Vascular scaffolds with enhanced antioxidant activity inhibit graft calcification. Biomaterials 144:166-175|
|Jiang, Bin; Suen, Rachel; Wang, Jiao-Jing et al. (2016) Mechanocompatible Polymer-Extracellular-Matrix Composites for Vascular Tissue Engineering. Adv Healthc Mater 5:1594-605|
|van Lith, Robert; Wang, Xuesong; Ameer, Guillermo (2016) Biodegradable Elastomers with Antioxidant and Retinoid-like Properties. ACS Biomater Sci Eng 2:268-277|
|Jiang, Bin; Suen, Rachel; Wertheim, Jason A et al. (2016) Targeting Heparin to Collagen within Extracellular Matrix Significantly Reduces Thrombogenicity and Improves Endothelialization of Decellularized Tissues. Biomacromolecules 17:3940-3948|
|Jiang, Bin; Jen, Michele; Perrin, Louisiane et al. (2015) SIRT1 Overexpression Maintains Cell Phenotype and Function of Endothelial Cells Derived from Induced Pluripotent Stem Cells. Stem Cells Dev 24:2740-5|
|Jiang, Bin; Akgun, Berke; Lam, Ryan C et al. (2015) A polymer-extracellular matrix composite with improved thromboresistance and recellularization properties. Acta Biomater 18:50-8|
|Jiang, Bin; Perrin, Louisiane; Kats, Dina et al. (2015) Enabling non-invasive assessment of an engineered endothelium on ePTFE vascular grafts without increasing oxidative stress. Biomaterials 69:110-20|
|van Lith, Robert; Gregory, Elaine K; Yang, Jian et al. (2014) Engineering biodegradable polyester elastomers with antioxidant properties to attenuate oxidative stress in tissues. Biomaterials 35:8113-22|
|Yang, Jian; van Lith, Robert; Baler, Kevin et al. (2014) A thermoresponsive biodegradable polymer with intrinsic antioxidant properties. Biomacromolecules 15:3942-52|